Reconstituting a 5mg vial of BPC-157 for injection is straightforward when you follow the right steps. The standard approach uses 2mL of bacteriostatic water, yielding a concentration of 2.5mg per mL and making a 250mcg dose equal to 0.1mL on an insulin syringe. This guide walks you through the entire process, from gathering supplies to calculating your exact dosage, so you can prepare your peptide safely and accurately.
What you need to reconstitute BPC-157 5mg
Before you start, assemble all necessary materials on a clean, disinfected surface. You will need one vial of lyophilized BPC-157 5mg, a vial of bacteriostatic water, alcohol swabs, and an insulin syringe with a fine needle, typically 30 or 31 gauge. Bacteriostatic water is preferred over sterile water because it contains 0.9% benzyl alcohol, which inhibits bacterial growth and allows multiple doses from the same vial. Do not use tap water, saline, or any other liquid not specifically designed for injection.
Wash your hands thoroughly with soap and water, then dry them with a clean towel. Wipe the rubber stoppers of both the BPC-157 vial and the bacteriostatic water vial with a fresh alcohol swab. Let them air-dry for at least 10 seconds to ensure disinfection. This step is critical to prevent contamination that could lead to infection or degrade the peptide.
Step-by-step reconstitution process
Begin by drawing air into your syringe equal to the volume of bacteriostatic water you plan to use. For a standard BPC-157 5mg reconstitution, that is 2mL. Insert the needle into the bacteriostatic water vial and inject the air to equalize pressure. Then, invert the vial and slowly pull back the plunger to draw exactly 2mL of water. Remove the needle and tap the syringe gently to dislodge any air bubbles, pushing the plunger slightly to expel them.
Now, insert the needle into the BPC-157 vial at a 45-degree angle, aiming the needle tip against the glass wall. This prevents the water stream from hitting the powder directly, which can damage the delicate peptide. Slowly depress the plunger to add all 2mL of bacteriostatic water. Once done, remove the needle and dispose of it safely in a sharps container.
Do not shake the vial. Instead, gently roll it between your palms or swirl it in a circular motion until the powder dissolves completely. The solution should become clear and colorless within a minute or two. If you see any cloudiness, particles, or discoloration, do not use it; this may indicate contamination or degradation. Store the reconstituted vial in the refrigerator at 2-8°C (36-46°F) and protect it from light.
Understanding your BPC-157 dosage after reconstitution
With 5mg of BPC-157 dissolved in 2mL of bacteriostatic water, the concentration is 2.5mg per mL. Since 1mL equals 100 units on an insulin syringe, each unit contains 25mcg of BPC-157. This simple math lets you adjust your dose precisely. Most research protocols use between 250mcg and 500mcg per injection, administered once or twice daily.
To inject 250mcg, draw 0.1mL, which is 10 units on an insulin syringe. For 500mcg, draw 0.2mL or 20 units. Always use a new, sterile syringe for each draw to maintain sterility. Wipe the vial stopper with alcohol before every use. If you prefer a different volume, you can reconstitute with 1mL of bacteriostatic water, which doubles the concentration to 5mg per mL. In that case, a 250mcg dose becomes 0.05mL or 5 units. However, using 2mL is more common because it allows easier measurement and reduces waste from dead space in the syringe.
BPC-157 dosage français: common protocols
For French-speaking researchers, le dosage de BPC-157 typically follows the same evidence-based ranges. The most studied dose for systemic healing is 250mcg to 500mcg injected subcutaneously or intramuscularly once or twice per day. Some protocols for acute injuries use up to 1mg daily, split into two 500mcg doses. Always start at the lower end to assess tolerance. BPC-157 has a short half-life of about 4 hours, so twice-daily dosing helps maintain stable levels in the body.
Injection sites depend on your goal. For localized healing, such as a knee or shoulder injury, inject as close to the affected area as possible, using a subcutaneous or intramuscular route. For gut health or systemic benefits, a subcutaneous injection into the abdomen is standard. Rotate injection sites to avoid tissue irritation. If you are also using other peptides like TB-500, you can find detailed guidance on TB-500 dosage per week for tissue repair to combine them effectively.
Calculating doses for different reconstitution volumes
If you choose to reconstitute with a different amount of water, the math changes. Here is a quick reference for a 5mg vial:
- 1mL bacteriostatic water: 5mg/mL concentration. 250mcg = 0.05mL (5 units), 500mcg = 0.1mL (10 units).
- 2mL bacteriostatic water: 2.5mg/mL concentration. 250mcg = 0.1mL (10 units), 500mcg = 0.2mL (20 units).
- 3mL bacteriostatic water: 1.67mg/mL concentration. 250mcg = 0.15mL (15 units), 500mcg = 0.3mL (30 units).
Always double-check your calculations. A common mistake is confusing milligrams and micrograms. Remember: 1mg = 1,000mcg. So 5mg equals 5,000mcg. If your target dose is 250mcg, you are injecting one-twentieth of the vial's total content.
Storage and stability after reconstitution
Once reconstituted, BPC-157 should be kept refrigerated and used within 30 days for best results. While some sources claim stability up to 60 days, peptide degradation can occur over time, especially if the vial is repeatedly entered. Always check for clarity before each use. Do not freeze reconstituted BPC-157, as ice crystals can damage the peptide structure. If you need to store it longer, consider keeping the lyophilized powder in the freezer and reconstituting only when ready to use.
Label your vial with the reconstitution date and concentration to avoid confusion. Use a small sticker or write directly on the vial with a marker. Keep the vial in a dark container or wrapped in foil to protect it from light, which can degrade peptides. Proper storage is as important as correct reconstitution for maintaining potency.
Safety precautions and best practices
Always use sterile technique. Never reuse syringes or needles. Dispose of sharps in a proper container. If you experience redness, swelling, or pain at the injection site, discontinue use and consult a healthcare professional. BPC-157 is for research purposes only and not approved for human consumption by regulatory agencies like the FDA or Health Canada. However, many researchers follow established protocols from scientific literature.
Before starting, consider your overall health context. For example, if you are using GLP-1 agonists for weight loss, you might be concerned about muscle preservation. In that case, explore how thymalin can counter GLP-1-induced muscle loss while BPC-157 supports tissue repair. Combining peptides should always be done with caution and under expert guidance.
Common reconstitution mistakes to avoid
One frequent error is using too much force when injecting the water, which can foam the peptide and reduce its effectiveness. Always add water slowly along the vial wall. Another mistake is failing to equalize pressure, causing a vacuum that makes drawing difficult. If you forget to inject air first, you can still equalize by pulling the plunger back after inserting the needle into the vial, but it is less precise.
Some users try to reconstitute with sterile water for injection, but this lacks a preservative and is only safe for single use. If you plan to use the vial over several weeks, bacteriostatic water is essential. Also, avoid touching the needle to any non-sterile surface. If you accidentally touch the needle, replace it with a new one before proceeding. These small steps prevent contamination and ensure your peptide remains safe.
How to inject BPC-157 subcutaneously
After drawing your calculated dose, choose an injection site with a layer of fat, such as the abdomen, thigh, or upper arm. Pinch the skin gently and insert the needle at a 90-degree angle if you have enough fat, or 45 degrees if you are lean. Inject the solution slowly and steadily. Withdraw the needle and apply light pressure with a clean cotton ball or alcohol swab. Do not rub the area, as this can cause bruising or disperse the peptide too quickly.
For intramuscular injections, common sites include the deltoid, glute, or quadriceps. Use a longer needle, typically 1 to 1.5 inches, and inject at a 90-degree angle. Aspirate briefly by pulling back the plunger to ensure you are not in a blood vessel. If blood appears, withdraw and choose a new site. Intramuscular injections may be preferred for deeper injuries, but subcutaneous is adequate for most purposes and is easier to perform.
Adjusting dosage based on research goals
Your dosage may vary depending on the condition being studied. For gut healing, such as leaky gut or inflammatory bowel disease, oral administration of BPC-157 is sometimes used, but injection remains the most studied route. For tendon and ligament repair, localized injections near the injury site at 250mcg to 500mcg twice daily are common. For systemic anti-inflammatory effects, the same dose range is used subcutaneously. Always refer to published studies for guidance,
For research and educational purposes only.